Drug
Fampridine
Fampridine: highest development phase Post-Market, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fampridine-SR NCT01656148 | Post-Market | Multiple Sclerosis |
Latest
No recent events.
Follow Fampridine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.